Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Rhotekin (RTKN) (N-Term) Peptide

RTKN Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN983306

Quick Overview for Rhotekin (RTKN) (N-Term) Peptide (ABIN983306)

Target

Rhotekin (RTKN)

Origin

Human

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-RTKN antibody (Catalog #: ARP56210_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    Rhotekin (RTKN)

    Background

    RTKN mediates Rho signaling to activate NF-kappa-B and may confer increased resistance to apoptosis to cells in gastric tumorigenesis. RTKN may play a novel role in the organization of septin structures.This gene encodes a scaffold protein that interacts with GTP-bound Rho proteins. Binding of this protein inhibits the GTPase activity of Rho proteins. This protein may interfere with the conversion of active, GTP-bound Rho to the inactive GDP-bound form by RhoGAP. Rho proteins regulate many important cellular processes, including cytokinesis, transcription, smooth muscle contraction, cell growth and transformation. Dysregulation of the Rho signal transduction pathway has been implicated in many forms of cancer. Alternative splicing results in multiple transcript variants encoding different isoforms.

    Alias Symbols: -

    Protein Interaction Partner: RHOA,RHOA,RHOA,RHOA,RTN4R,GOPC,RAC2,RHOA,RHOC,SMURF1,TAX1BP3,TGFBR1,RHOA,RHOA

    Protein Size: 563

    Molecular Weight

    63 kDa

    Gene ID

    6242

    NCBI Accession

    NM_001015055, NP_001015055

    UniProt

    Q9BST9
You are here:
Chat with us!